CStone Pharmaceuticals Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CStone Pharmaceuticals Co., Ltd. - overview
Established
2015
Location
Suzhou, -, China
Primary Industry
Pharmaceuticals
About
Founded in 2015 and based in Suzhou, China, CStone Pharmaceuticals Co. , Ltd. researches and develops biopharmaceutical therapeutics focused on immuno-oncology and molecular targeting for treating cancer.
Current Investors
Oriza Holdings, Boyu Capital, 6 Dimensions Capital
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.cstonepharma.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
CStone Pharmaceuticals Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - |
| EBITDA (USD) | 69,000 | 821,000 | (1,795,810,000) | - | - | - |
| Operating Income (USD) | - | - | (1,801,076,000) | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - |
| NET Income (USD) | (253,039,000) | (342,547,000) | (1,793,129,000) | - | - | - |
| % Net Margin | - | - | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.